Talphera (TLPH) Return on Equity [ROE] (2011 - 2026)
Talphera's Return on Equity [ROE] was -91.69% in Q2 2026, up 93.24 percentage points from -184.93% a year earlier but down 11.42 percentage points from the prior quarter.
Talphera (TLPH) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Talphera came in at -114.16%, up 3.50 percentage points from FY2024.
- In earlier years, Return on Equity [ROE] was -117.65% in FY2024 (-15.22 pp) and -102.44% in FY2023.
- Quarterly Return on Equity [ROE] has moved between -217.00% (Q2 2023) and 267.79% (Q1 2023) over five years.
- Compared with a year earlier, Return on Equity [ROE] has increased for four straight quarters, with an average year-over-year change of +12.83 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2024 (a gain of 123.03 percentage points); the worst was Q1 2024 (a drop of 361.08 percentage points).
- Per Business Quant data, TLPH's Return on Equity [ROE] in the three quarters before Q2 2026 was -80.27% (Q1 2026), -78.92% (Q4 2025) and -96.02% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | Talphera | 80.06 Mn | 62.98 Mn | - | -91.69% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91.69% |
| Mar 31, 2026 | -80.27% |
| Dec 31, 2025 | -78.92% |
| Sep 30, 2025 | -96.02% |
| Jun 30, 2025 | -184.93% |
| Mar 31, 2025 | -171.22% |
| Dec 31, 2024 | -147.42% |
| Sep 30, 2024 | -139.92% |
| Jun 30, 2024 | -93.97% |
| Mar 31, 2024 | -93.29% |
| Dec 31, 2023 | -113.52% |
| Sep 30, 2023 | -148.74% |
| Jun 30, 2023 | -217.00% |
| Mar 31, 2023 | 267.79% |
| Dec 31, 2022 | 194.76% |
| Sep 30, 2022 | 156.78% |
| Sep 30, 2016 | -525.00% |
| Jun 30, 2016 | -149.16% |
| Mar 31, 2016 | -89.66% |
| Dec 31, 2015 | -66.77% |
Talphera Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TLPH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TLPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TLPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();